136 related articles for article (PubMed ID: 10495262)
1. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
LeBlanc ES; Viscoli CM; Henrich JB
J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
[TBL] [Abstract][Full Text] [Related]
2. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
3. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
6. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal estrogen use and invasive versus in situ breast cancer risk.
Henrich JB; Kornguth PJ; Viscoli CM; Horwitz RI
J Clin Epidemiol; 1998 Dec; 51(12):1277-83. PubMed ID: 10086820
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
9. Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions.
Vassilopoulou-Sellin R; Klein MJ
Cancer; 1996 Sep; 78(5):1043-8. PubMed ID: 8780542
[TBL] [Abstract][Full Text] [Related]
10. The risks and benefits of estrogen replacement therapy: Leisure World.
Paganini-Hill A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy in the elderly.
Paganini-Hill A
Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
[TBL] [Abstract][Full Text] [Related]
12. Unopposed estrogen therapy and the risk of invasive breast cancer.
Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL
Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
[TBL] [Abstract][Full Text] [Related]
16. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
17. Reduced mortality associated with long-term postmenopausal estrogen therapy.
Ettinger B; Friedman GD; Bush T; Quesenberry CP
Obstet Gynecol; 1996 Jan; 87(1):6-12. PubMed ID: 8532268
[TBL] [Abstract][Full Text] [Related]
18. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
Vassilopoulou-Sellin R; Theriault RL
J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
[TBL] [Abstract][Full Text] [Related]
19. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study.
Zhang Y; McAlindon TE; Hannan MT; Chaisson CE; Klein R; Wilson PW; Felson DT
Arthritis Rheum; 1998 Oct; 41(10):1867-73. PubMed ID: 9778229
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement therapy and breast cancer survival in a large screening study.
Schairer C; Gail M; Byrne C; Rosenberg PS; Sturgeon SR; Brinton LA; Hoover RN
J Natl Cancer Inst; 1999 Feb; 91(3):264-70. PubMed ID: 10037105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
